405 related articles for article (PubMed ID: 7508663)
1. [New concepts in therapy of type I allergic diseases].
Valenta R; Steinberger P; Vrtala S; Grote M; Laffer S; Sperr WR; Valent P; Kraft D; Scheiner O
Wien Klin Wochenschr; 1993; 105(23):682-6. PubMed ID: 7508663
[TBL] [Abstract][Full Text] [Related]
2. Allergen-related approaches to immunotherapy.
Rolland JM; Gardner LM; O'Hehir RE
Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
[TBL] [Abstract][Full Text] [Related]
3. Genetic engineering of pollen allergens for hayfever immunotherapy.
Bhalla PL
Expert Rev Vaccines; 2003 Feb; 2(1):75-84. PubMed ID: 12901599
[TBL] [Abstract][Full Text] [Related]
4. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
Mutschlechner S; Deifl S; Bohle B
Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
[TBL] [Abstract][Full Text] [Related]
5. [Hyposensitization].
Przybilla B; Ring J
Internist (Berl); 1991 Oct; 32(10):606-11. PubMed ID: 1761393
[No Abstract] [Full Text] [Related]
6. Recombinant allergen-specific antibody fragments: tools for diagnosis, prevention and therapy of type I allergy.
Valenta R; Flicker S; Eibensteiner PB; Steinberger P; Laffer S; Dolecek C; Kraft D
Biol Chem; 1997 Aug; 378(8):745-9. PubMed ID: 9377468
[TBL] [Abstract][Full Text] [Related]
7. Immunological mechanisms of allergen-specific immunotherapy.
Jutel M; Akdis CA
Allergy; 2011 Jun; 66(6):725-32. PubMed ID: 21466562
[TBL] [Abstract][Full Text] [Related]
8. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
Crameri R
Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
[TBL] [Abstract][Full Text] [Related]
9. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
Valenta R; Vrtala S; Focke-Tejkl M; Bugajska-Schretter ; Ball T; Twardosz A; Spitzauer S; Grönlund H; Kraft D
Biol Chem; 1999; 380(7-8):815-24. PubMed ID: 10494830
[TBL] [Abstract][Full Text] [Related]
10. Allergen-specific immunotherapy.
Niederberger V
Immunol Lett; 2009 Feb; 122(2):131-3. PubMed ID: 19100771
[TBL] [Abstract][Full Text] [Related]
11. Synthetic and genetically engineered allergen derivatives for specific immunotherapy of type I allergy.
Valenta R; Vrtala S; Focke-Tejkl M; Twardosz A; Swoboda I; Bugajska-Schretter A; Spitzauer S; Kraft D
Clin Allergy Immunol; 2002; 16():495-517. PubMed ID: 11577556
[No Abstract] [Full Text] [Related]
12. B-cell epitopes of allergens determined by recombinant techniques; use for diagnosis and therapy of type I allergy.
Valenta R; Vrtala S; Laffer S; Steinberger P; Ball T; Ferreira F; Scheiner O; Kraft D
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):235-46. PubMed ID: 7532944
[TBL] [Abstract][Full Text] [Related]
13. Strategies for converting allergens into hypoallergenic vaccine candidates.
Vrtala S; Focke-Tejkl M; Swoboda I; Kraft D; Valenta R
Methods; 2004 Mar; 32(3):313-20. PubMed ID: 14962766
[TBL] [Abstract][Full Text] [Related]
14. The current state of recombinant allergens for immunotherapy.
Pauli G; Malling HJ
Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
[TBL] [Abstract][Full Text] [Related]
15. Molecular and immunologic characterization of a highly cross-reactive two EF-hand calcium-binding alder pollen allergen, Aln g 4: structural basis for calcium-modulated IgE recognition.
Hayek B; Vangelista L; Pastore A; Sperr WR; Valent P; Vrtala S; Niederberger V; Twardosz A; Kraft D; Valenta R
J Immunol; 1998 Dec; 161(12):7031-9. PubMed ID: 9862740
[TBL] [Abstract][Full Text] [Related]
16. Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens.
Pittner G; Vrtala S; Thomas WR; Weghofer M; Kundi M; Horak F; Kraft D; Valenta R
Clin Exp Allergy; 2004 Apr; 34(4):597-603. PubMed ID: 15080813
[TBL] [Abstract][Full Text] [Related]
17. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
Wilcock LK; Francis JN; Durham SR
Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
[TBL] [Abstract][Full Text] [Related]
18. Structural, immunological and functional properties of natural recombinant Pen a 1, the major allergen of Brown Shrimp, Penaeus aztecus.
Reese G; Schicktanz S; Lauer I; Randow S; Lüttkopf D; Vogel L; Lehrer SB; Vieths S
Clin Exp Allergy; 2006 Apr; 36(4):517-24. PubMed ID: 16630158
[TBL] [Abstract][Full Text] [Related]
19. Microarrayed allergens for IgE profiling.
Deinhofer K; Sevcik H; Balic N; Harwanegg C; Hiller R; Rumpold H; Mueller MW; Spitzauer S
Methods; 2004 Mar; 32(3):249-54. PubMed ID: 14962759
[TBL] [Abstract][Full Text] [Related]
20. Peptide and recombinant immunotherapy.
Larché M
Immunol Allergy Clin North Am; 2011 May; 31(2):377-89, xi. PubMed ID: 21530826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
